Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1974 Jun;37(6):711–714. doi: 10.1136/jnnp.37.6.711

Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects

Barbara P Hilton 1
PMCID: PMC494752  PMID: 4844137

Abstract

Platelet aggregation experiments confirm differences between the 5-hydroxytryptamine (5-HT) receptors of migrainous and control platelets. However, no differences have been found in 5-HT uptake, in the presence of reserpine or chlorpromazine, into migrainous and control platelets. The results support the hypothesis that receptors for 5-HT induced platelet aggregation provide a model for vascular receptors causing constriction and are distinct from those transferring 5-HT through the platelet membrane.

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner H. R., Born G. V. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968 Apr 13;218(5137):137–141. doi: 10.1038/218137a0. [DOI] [PubMed] [Google Scholar]
  2. Born G. V., Juengjaroen K., Michal F. Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues. Br J Pharmacol. 1972 Jan;44(1):117–139. doi: 10.1111/j.1476-5381.1972.tb07244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cumings J. N., Hilton B. P. Effects of methysergide on platelets incubated with reserpine. Br J Pharmacol. 1971 Aug;42(4):611–619. doi: 10.1111/j.1476-5381.1971.tb07145.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  5. HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hilton B. P., Cumings J. N. 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):505–509. doi: 10.1136/jnnp.35.4.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hilton B. P., Cumings J. N. An assessment of platelet aggregation induced by 5-hydroxytryptamine. J Clin Pathol. 1971 Apr;24(3):250–258. doi: 10.1136/jcp.24.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Michal F. D-receptor for serotonin on blood platelets. Nature. 1969 Mar 29;221(5187):1253–1254. doi: 10.1038/2211253a0. [DOI] [PubMed] [Google Scholar]
  9. Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother. 1968 Jan;32(1):1–16. doi: 10.1111/j.1476-5381.1968.tb00423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES